In December 2013, HHP was engaged by Jiangxi Boya Bio-Pharmaceutical Co., Ltd. (Stock Code: 300294) to provide legal advice when its wholly-owned subsidiary, Jiangxi Boya Pharmaceutical Investment Co., Ltd. participated in the public auction on the 55.586% share transfer of Guizhou Tian’an Pharmaceutical Co., Ltd., which is the holding subsidiary of Guizhou Chitianhua Co., Ltd. (Stock Code: 600227). The transaction amount was RMB 184,450,000.